Summary Human liver carcinoma cells 
cis-Diamminedichloroplatinum II (cisplatin) has become a major chemotherapeutic agent in clinical treatment of tumours since it was found to have anti-cancer activity two decades ago. Cisplatin is used particularly for treatment of solid tumours, such as testicular cancer, ovarian cancer, bladder cancer, cancer of the head and neck and small-cell lung carcinomas (Loehrer and Einhorn, 1984) . However, as with all anti-cancer drugs, many tumours show intrinsic resistance to cisplatin or develop resistance after initially responding to treatment. One well-studied example is the development of multidrug resistance (MDR) to agents such as vinca alkaloids, anthracyclines, taxol and epipodophyllotoxins. Multidrug resistance is commonly associated with expression of the MDR1 gene, which encodes the 170 000 M, membrane P-glycoprotein, an ATP-dependent efflux pump which prevents accumulation of drugs in resistant cells (Gottesman and Pastan, 1993) . Resistance to cisplatin does not result from overexpression of the MDR1 gene and has been postulated to be associated with several different cellular changes, including reduced accumulation of the drug (Richon et al., 1987) , increased levels of intracellular metallothionein and glutathione or enzymes involved in glutathione metabolism (Moscow and Cowan, 1988; Kasahra et al., 1991; Shellard et al., 1991; Timmer-Bosscha et al., 1992) , including elevated expression of mRNAs for 7-glutamylcysteine synthetase and 'y-glutamyltranspeptidase (Godwin et al., 1992) , increases in thymidylate synthase (Newman et al., 1988) , enhanced DNA repair (Plooy et al., 1985; Masuda et al., 1988) or the presence of DNA-binding proteins recognising damaged DNA (Chu and Chang, 1990) . The exact mechanisms of resistance to cisplatin during chemotherapy requires further elucidation.
A number of cell lines with different levels of resistance to cisplatin have been isolated from human ovarian carcinoma, small-cell lung cancer and colon cancer, as well as from several murine cell lines. To further understand intrinsic resistance to cisplatin and the development of high-level resistance to cisplatin, we have established a series of highly cisplatin-resistant cell lines from an intrinsically cisplatinresistant human liver carcinoma cell line, BEL-7404, and from cisplatin-sensitive KB adenocarcinoma cells to explore common features related to cisplatin resistance in two different human cell lines.
Materials and methods

Cell lines and cell culture
The human liver carcinoma cell line, BEL-7404, was selected for resistance to cisplatin. The biological characteristics of this cell line have been previously described in detail (Shen and Chen, 1985) . A series of cisplatin-resistant BEL-7404 populations were selected by stepwise increases in cisplatin concentration from 300 ng ml-' to 20 jig ml-' of medium over a period of 24 months. For comparison purposes, the human epidermoid carcinoma cell line KB-3-1, a subclone of the human HeLa cervical adenocarcinoma cell line, was mutagenised with 200 jg ml' ethyl methanesulphonate (EMS) for 24 h, and also selected for resistance to cisplatin by stepwise Correspondence: MM Gottesman, Building 37, Room 1B22, 37 Convent DR MSC 4255, Bethesda MD 20892-4255, USA increases in cisplatin from 200 ng ml1' to 20 fig ml1' of medium. The KB-Cl.5 cell line (Shen et al., 1986 ) is a colchicine-selected MDR 1-expressing derivative maintained in 1.5pgml-' colchicine and was used for comparison of protein patterns. All cell lines were grown as monolayer cultures at 37°C in 5% carbon dioxide, using Dulbecco's modified Eagle medium with 4.5 g I1 glucose (Gibco), supplemented with L-glutamine, penicillin, streptomycin and 12% fetal bovine serum (Whittaker, MA Bioproducts). The human liver carcinoma cell line, BEL-7404, was adopted for the selection of cisplatin resistance because this cell line shows little expression of the MDR1 gene and a higher level of intrinsic resistance to cisplatin than KB-3-1 cells (Shen et al., 1991) . After 2 weeks of exposure to 300 ng ml-' cisplatin, a few colonies appeared in the presence of cisplatin. Cells were trypsinised and the whole cell population was pooled and designated (i.e. BEL-7404 cells growing in medium containing 0.3 fg ml-' cisplatin). Over a period of 18 months, cisplatin was increased in steps (see Figure la) and resistant colonies were pooled as above until the hepatoma cells grew in 7.5 iLg ml-' cisplatin (CP7.5 Figure lb . The cisplatin-resistant cell line, (maintained in 5 jig ml-' cisplatin), and its partially reverted cell line, KB-CP5-df365 (drug free for more than 1 year), were used for these biochemical studies. In addition, KB-CPIO and KB-CP20 cell lines were also developed from KB-CP5 and maintained in 10 and 20 ltg ml-' cisplatin respectively.
Cisplatin resistance levels The killing curves shown in Figure 2a indicate the resistance levels of the human hepatoma cell line, BEL-7404, and its cisplatin-selected resistant cell lines. The KB-3-1 cell line and its CPr cell lines are also shown in Figure 2b . The relative resistance level for 7404-CP7.5 was 111-fold higher than for its parental cell line BEL-7404. The first-step cisplatinresistant hepatoma CPr cell line, 7404-CP.3, and the intermediate steps, 7404-CPI and 7404-CP5, are 18.3-, 33.4-and 71.6-fold more resistance to cisplatin than their parental cell line, BEL-7404, respectively. The 7404-CP7.5-dfl55 cell line, maintained in cisplatin-free medium for 155 days, still maintained a resistance level of 31.2-fold, equivalent to that of 7404-CPI. KB-CP-10, and its earlier step resistant line, KB-CP5, were 1152 and 787 times more resistant than the parental KB-3-1 cells respectively. However, the IC50 value of 7404-CP7.5 was 49 Lg ml-, which was higher than the KB-CPIO cells (38;Lg ml-'). As previously noted, the hepatoma cells exhibited higher basal levels of resistance to cisplatin than the KB cells (Shen et al., 1991) .
Cross-resistance levels
To determine the cross-resistance patterns in both hepatoma and KB cell lines, several agents were examined. The patterns of cross-resistance in parental and cisplatin-resistant human liver carcinoma cells are listed in Table I lines. However, the KB-CP1O cells were also somewhat crossresistant to mitomycin C, and the 7404-CP7.5 cells were not.
Protein patterns detected by one-dimensional SDS-PAGE Cytosolic soluble fractions isolated from sensitive and cisplatin-resistant cell lines were analysed by one-dimensional protein electrophoresis, followed by Coomassie blue staining. Figure 3 shows that alterations in the amounts of specific polypeptides could be detected in several regions. A 90 kDa protein band was increased in the 7404-CPF cells as compared with the parental cell line BEL-7404, but not obviously changed in the KB-CP20 cells. However, the density of proteins of molecular weight 52 kDa was increased in the 7404 CP20 cells and slightly increased in the KB-CP20 cells by 2.5-fold and 1.3-fold respectively as determined by scanning using AMBIS QuantProbe Software, and the results are shown in Figure 5a . The cell line 7404-CP20-dfl55 maintained in the absence of cisplatin for 155 days still retained levels similar to its parental resistant cell line 7404-CP20. Reduction of protein bands also occurred in the cisplatinresistant cell lines. A band of approximately 35 kDa in both 7404-CP20 and KB-CP20 cells was less dense than in the parental cell lines, while a dramatically reduced band at 57 kDa was only observed in the KB-CP20 cells. Protein changes were also found in the pelleted crude membrane fractions, as shown in Figure 4 . KB-C 1.5 is a colchicine-resistant cell line which overexpresses the MDR1 Figure 5b , the 7404-CP.3 cell line, which was the first-step cisplatin-resistant hepatoma subline maintained in 300 ng ml1-cisplatin, showed about a 45% increase intensity in the 52 kDa protein as compared with its parental cell line BEL-7404, while 7404-CPI and 7404-CP7.5, which were maintained in 1 and 7.5 jg mlcisplatin, showed a 100% and 140% increase respectively. In the KB-CPIO cells, however, only a 55% increase was found when compared with the parental KB-3-1 cells, which had a higher basal level of this protein. There were no obvious differences between KB-3-1 cells and an MDRl-expressing cell line, KB-Cl.5 (Figure 5b ). (Figure 6b ) when compared with the parental BEL-7404 cells (Figure 6a ). The R arrows in the parental BEL-7404 cells indicate the locations of proteins that were reduced in the cisplatin-resistant cells. Numerous increases or decreases in proteins could also be detected in KB-CPr cells compared with the cisplatin-sensitive parental KB-3-l cells as indicated by arrows I and R as shown in Figure 6c and Figure 5 Histograms showing semiquantitative changes in the 52 kDa protein in cytosolic soluble fractions (a) and in the crude membrane fraction (b), as seen in Figure 3 and 4 respectively. The 52 kDa protein was scanned with the AMBIS Radioanalytic Imaging System using AMBIS QuantProbe Software. polypeptides of 52 and 50 kDa were increased, and five proteins were decreased, as shown in Figure 7a and b. Figure 7c and d shows two-dimensional gels of KB-3-1 and KB-CPI0 cells, in which the 1-52 and 1-50 proteins were also overexpressed in the cisplatin-resistant cells.
To identify the nature of the 52 kDa protein, cytosoluble fractions isolated from BEL-7404 and 7404-CP20 cells were subjected to two-dimensional electrophoresis, then transblotted onto polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were stained with 0.1% Coomassie brilliant blue to localise the overexpressed polypeptides. The 52 kDa polypeptide spots were collected for amino acid microsequencing. The result indicated that seven amino acids were recognised as follows: Asp-Val-Lys-Phe-Gly-Ala-Asp. This sequence is 100% identical to the amino terminus of the mitochondrial matrix protein P1, also known as heat shock protein hsp6O. Using a human specific hsp6O monoclonal antibody and the ECL kit, Figure 8a and (Chu and Chang, 1990) , increased levels of intracellular thiols and reduced accumulation of cisplatin (Richon et al., 1987; Andrews and Howell, 1990 ). However, no one mechanism has been uniformly present in all cisplatinresistant cells examined. In this work, we find that two human cell lines selected for high-level resistance to cisplatin, which also show similar patterns of cross-resistance to methotrexate, 5-FU and 6-MP, manifest many changes in protein levels, but share an increase in polypeptides of molecular weight 52 and 50 kDa.
The human liver carcinoma cell line BEL-7404 was chosen as a model system to study cisplatin resistance because of its intrinsic resistance to this agent and in the hope that further selection in cisplatin would amplify the effect of its intrinsic resistance mechanism. Thus, it should be feasible to determine which biochemical alterations are responsible for the intrinsic and acquired cisplatin resistance of these cells with the central goal of creating sensitive molecular probes of clinical tumour specimens. A comparison of cisplatin resistance between the BEL-7404 hepatoma cells and KB-3-1 adenocarcinoma cells showed that the hepatoma cells were about 13-fold more resistant, without selection, than the KB-3-1 cells. After selection in cisplatin, the ICm values for the 7404-CP7.5 cells and the KB-CP1O cells were 49 and 38 fig ml-' cisplatin respectively, which was almost one thousand times higher than the parental KB-3-1 cells. We would like to determine the basis for such high-level resistance to cisplatin, which is not commonly seen in cell lines selected in vitro for resistance to this agent.
It has been reported that cells acquiring cisplatin resistance also develop resistance to alkylating agents and other types of DNA-damaging chemicals (Frei et al., 1985) . 7404-CPF cells showed a limited degree of resistance to a bifunctional agent, melphalan (2.6-fold), that was similar to results previously described (Puchalski and Fahl, 1990) , while the KB-CP1O cells were about 11-fold more resistant than the parental KB-3-1 cells. Interestingly, both 7404-CPF and KB-CPF cells demonstrated cross-resistance to methotrexate, about 39-and 20-fold relative to their sensitive parental cell (Newman et al., 1988) . In a recent study on mouse Balb/3T3 cisplatin-resistant cell lines transformed with human genomic DNAs isolated from human hepatoma 7404-CP7.5 cells, cross-resistance to methotrexate also occurred (unpublished data of the authors). The human cisplatin-resistant hepatoma cells also showed cross-resistance to 5-fluorouracil and 6-mercaptopurine by 23.0-and 12.9-fold relative to the parental cells respectively. Similar patterns but lower resistance levels to 5-fluorouracil and 6-mercaptopurine were also found in the KB-CP1O cells.
These results suggest that this cross-resistance, particularly to methotrexate, may be a consequence of a common, novel mechanism of multidrug resistance. This cross-resistance may be related to nucleotide pools since cross-resistance primarily affects nucleotide derivatives, or could be associated with export of drug metabolites via an ATP-dependent glutathione S-conjugate export pump (Ellis, 1990; Ishikawa and Ali-Osman, 1993 (Jekunen et al., 1994) .
No cross-resistance to the MDR substrates colchicine, vinblastine, actinomycin D, mitomycin C and VP-16, or to non-MDR substrate hydroxyurea was found in the hepatoma CP7.5 cells. Some cross-resistance to actinomycin D, doxorubicin, mitomycin C and hydroxyurea was observed in the KB-CPIO cells. These results support the hypothesis that there is no single pattern of resistance associated with selection in cisplatin and that the multiple steps of selection used in this study undoubtedly gave rise to several different resistance mechanisms.
To begin our analysis of the basis of drug resistance in these highly cisplatin-resistant human cell lines, we compared patterns of protein expression seen in KB-CP1O and CP7.5 cells. Alterations in the steady-state amount of several different polypeptides were repeatedly detected in both soluble cytosolic and crude membrane fractions by regular SDS- t PAGE or two-dimensional SDS-PAGE. When comparing the differences between the cisplatin-resistant cells and their sensitive parental cells, one feature common to 7404-CPF and KB-CPF was the overexpression of a 52 kDa protein(s) in the pelleted membrane and cytosolic fractions of both the hepatoma and the KB cisplatin-resistant cell lines. The content of this protein(s) in crude membrane fractions increased in parallel with increased cisplatin resistance in the 7404-CPr cell lines, and reduced amounts were found in the revertant KB-CP5-df365 cells which had been maintained in cisplatinfree medium for more than 1 year. The resistance of this KB-CP5-df365 cell line to cisplatin was remarkably reduced from its original 788 times to 21 times higher than the sensitive parental KB-3-1 cells. However, the 52kDa protein(s) was still increased to some extent in a partially reverted cisplatin-resistant hepatoma cell line, 7404-CP20-dfl55, which retained 31-fold more resistance to cisplatin than its sensitive parental cells. This continued expression of cisplatin resistance and of 52kDa protein(s) indicates that cisplatin resistance is a relatively stable change in cells, and that the increase in the 52 kDa protein(s) is also probably a stable change rather than a transient event such as a toxic response to cisplatin. Further evidence that the 52 kDa protein is not increased directly in response to cisplatin treatment came from an experiment in which the sensitive parental BEL-7404 cells were exposed to cisplatin at 1.5 ig ml' for 1, 3, and 17 h (data not shown). In this experiment, no increase in 52 kDa proteins was observed. Compared with KB-CPI0 cells, elevations and reductions in several other proteins of different molecular weight were also observed, but no other changes were shared by both the hepatoma and the KB cell lines.
Recent studies indicate that 52 kDa protein(s) can also be detected in primary and secondary transfectants of mouse Balb/3T3 cells transformed to express cisplatin resistance with high molecular weight DNA from cisplatin-resistant human hepatoma 7404-CP7.5 cells, suggesting that the 52 kDa proteins may play a role, directly or indirectly, in cisplatin resistance (DW Shen, I Pastan and MM Gottesman, in preparation). Amino acid microsequencing of the 52 kDa spots indicates that there is 100% identity for seven amino acids to the human heat shock protein, hhsp60, a chaperonin. Using immunoblots reacted with a human specific monoclonal antibody directed to hsp60 further confirmed that heat shock protein 60 was elevated in CPF cells from both hepatoma and KB cell lines. There were no detectable changes in hsp7o between sensitive and CPF cell lines tested in this study. Work by Howell's group has also identified hsp60 as a protein overexpressed in cisplatin-resistant cells (Kimura et al., 1993) . At this time, we can only speculate on the possible functions of an elevation in hsp60 in cisplatinresistant human cancer cells. hsp60 is a homologue of GroEL and a highly conserved intrinsic mitochondrial protein. As a member of the chaperonin family, it is generally accepted that the hsp60 probably mediates the correct folding of polypeptides, and in some cases their assembly into oligomeric structures. hsp60 may also function by binding specifically and non-covalently to interactive protein surfaces that are exposed transiently during cellular processes such as protein synthesis, protein transport across membranes and stress responses (Ellis, 1990) . Whether overexpression of hsp60 protects cells from toxic effects of cisplatin is as yet unclear.
Of the other protein changes, only the overexpressed 1-90 protein in the soluble fractions of cisplatin-resistant cells could be tentatively identified as a stress-related heat shock protein, hsp90, as its isoelectric point (Figure 6b ) is quite similar to that reported for hsp90 on the two-dimensional map of transformed amnion cells (Celis et al., 1990) . The altered expression of other proteins, in either 7404 or KB cisplatin-resistant cells, demonstrates that profound phenotypic alterations occurred during acquisition of resistance to the agent. However, the changes in these proteins may not be directly responsible for resistance to cisplatin, but may reflect a response to stress and/or represent changes needed for survival and proliferation of cells exposed to cisplatin.
In these studies, the 200kDa protein found in cisplatinresistant murine lymphoma cells (Kawai et al., 1990) was not detected in our CPT cell lines by SDS-PAGE. In addition, no elevated expression of P-glycoprotein, the MDR1 gene product, was found as compared with KB-C1.5, an MDR1 gene-expressing cell line. Expression of the MDR1 gene was undetectable by Northern or RNA slot-blot hybridisation with the specific MDR1 cDNA probe pHDR5A (Ueda et al., 1987 and results not shown). Neither extrachromosomal DNA (episomes) nor double minute (DM) chromosomes could be identified by pulsed-field gradient gel electrophoresis (PFGE) or karyotypic analysis. In addition, the native MDR locus, which is contained within a 330 kb SfiI fragment, was intact and unamplified as determined by PFGE analysis (Schoenlein et al., 1992 , and data not shown).
Recently, changes in DNA damage repair proteins, DNAbinding proteins, chromosomal protein HMG1 and nuclear matrix proteins were found in cisplatin-resistant cells (Chu and Chang, 1990; Clugston et al., 1992; de Jong et al., 1992; Pil and Lippard, 1992; Zhen et al., 1992) . Some types of glutathione S-transferase, glutamylcystine synthetase and thymidylate synthetase have also been reported to increase during development of cisplatin resistance (Behrens et al., 1987; Scanlon and Kashani-Sabet, 1988; Puchalski and Fahl, 1990; Godwin et al., 1992) . Taken together with the results in this paper, cisplatin resistance appears to result from many different mechanisms affecting function of the nucleus, cytoplasm and membranes. Which of these mechanisms is most common and which, if any, are clinically relevant, remains to be determined.
Abbreviations: cisplatin, cis-diamminedichloroplatinum(II); CPr, cisplatin resistance; SDS-PAGE, sodium dodecyl sulphate-polyacrylamide gel electrophoresis; DMS, double minutes (chromosomes); EMS, ethyl methanesulphonate.
